Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a Phase Ⅲ randomized, controlled, multi-center, trial comparing cisplatin plus
docetaxel to cetuximab, cisplatin, and docetaxel induction chemotherapy followed by
concurrent chemoradiation in previously untreated patients metastatic nasopharyngeal
carcinoma (mNPC) to determine whether the addition of cetuximab to induction chemotherapy and
chemoradiation could improve therapeutic efficacy in mNPC, and investigate predictive and
prognostic factors for mNPC.